Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced today the launch of Biofourmis Care, a first of its kind, technology-enabled care management service that delivers high-quality remote care for patients with chronic conditions. The service includes automated medication management to augment and assist care teams in remotely adjusting medications for optimal personalized therapy. Biofourmis Care is purpose built to improve health outcomes and reduce total cost of care among patients with complex chronic diseases by improving provider adherence to guideline-recommended care and detecting patterns of clinical deterioration for earlier interventions.
Biofourmis’ Care@Home technology platform now spans the entire care continuum with Hospital@Home for acute conditions; remote patient management for post-discharge care; and now, virtual specialty care for longitudinal chronic disease management.
Biofourmis Care currently includes five virtual care programs: heart failure, hypertension, diabetes, lipid management and atrial fibrillation. The specialty care programs are delivered remotely by Biofourmis’ trained health navigators, who are frontline care coordinators, as well as a multidisciplinary team of licensed clinicians, including physicians, nurses and advanced practice providers. For seamless care coordination, these virtual care teams partner with the patient’s pre-existing, on-the-ground primary and specialty care providers.
Biofourmis Care is able to meet the patient where they are on their journey: The platform can co-manage multiple chronic diseases at once, tailor the intensity and cadence of services delivered to match the severity of the patient’s illness, and integrate personalized information to individualize automated medication initiation and titration algorithms.
Specialty care accounts for 70% of all healthcare spending in the United States, and up to 40% of specialty care visits are deemed avoidable. In addition, one in four patients do not have easy and timely access to specialists. This approach helps close those gaps.
There has been a lot of focus on primary care as value-based care continues to expand; however, our novel virtual specialty care model will have an outsized impact on reducing total cost of care and improving quality of life and health outcomes, said Maulik Majmudar, MD, chief medical officer and co-founder of Biofourmis and cardiologist. That’s because our robust care management platform is augmented by sophisticated software algorithms for medication optimization and supported by a 24/7 clinical care team.
Biofourmis’ highly qualified clinical team augments patients’ primary care and specialist providers in:
- Managing their chronic conditions
- Improving care quality through adherence to guideline-directed medical therapies (GDMT)
- Identifying patients with early signs of clinical deterioration through artificial intelligence (AI) and machine learning-based algorithms
- Driving timely interventions with the goal of improving patient outcomes.
Biofourmis Care offers clinical and financial return on investment for providers, payers and value-based organizations such as ACOs through timely, efficient and safer optimization of evidence-based therapies, which supports reduction in total cost of care, including emergency department visits and hospital admissions.
Our Care@Home platform enables health systems and payers to deploy virtual care programs across a wide range of clinical conditions, patient acuity levels and care settings. Biofourmis Care takes our value proposition a step further, said Kuldeep Singh Rajput, CEO and founder of Biofourmis. Our licensed and highly qualified clinical care teams will be an extension of the health system’s or physician’s care team, virtually engaging patients, coaching them on adherence, and monitoring their vitals to safely prevent hospitalizations and improve quality of life.
More details here
